332 related articles for article (PubMed ID: 18046314)
1. Reduction of anionic sites in the glomerular basement membrane by heparanase does not lead to proteinuria.
van den Hoven MJ; Wijnhoven TJ; Li JP; Zcharia E; Dijkman HB; Wismans RG; Rops AL; Lensen JF; van den Heuvel LP; van Kuppevelt TH; Vlodavsky I; Berden JH; van der Vlag J
Kidney Int; 2008 Feb; 73(3):278-87. PubMed ID: 18046314
[TBL] [Abstract][Full Text] [Related]
2. Heparanase Is Essential for the Development of Acute Experimental Glomerulonephritis.
Garsen M; Benner M; Dijkman HB; van Kuppevelt TH; Li JP; Rabelink TJ; Vlodavsky I; Berden JH; Rops AL; Elkin M; van der Vlag J
Am J Pathol; 2016 Apr; 186(4):805-15. PubMed ID: 26873445
[TBL] [Abstract][Full Text] [Related]
3. Heparanase in glomerular diseases.
van den Hoven MJ; Rops AL; Vlodavsky I; Levidiotis V; Berden JH; van der Vlag J
Kidney Int; 2007 Sep; 72(5):543-8. PubMed ID: 17519955
[TBL] [Abstract][Full Text] [Related]
4. Heparanase induces a differential loss of heparan sulphate domains in overt diabetic nephropathy.
Wijnhoven TJ; van den Hoven MJ; Ding H; van Kuppevelt TH; van der Vlag J; Berden JH; Prinz RA; Lewis EJ; Schwartz M; Xu X
Diabetologia; 2008 Feb; 51(2):372-82. PubMed ID: 18058084
[TBL] [Abstract][Full Text] [Related]
5. Heparan sulfate--rich anionic sites in the human glomerular basement membrane. Decreased concentration in congenital nephrotic syndrome.
Vernier RL; Klein DJ; Sisson SP; Mahan JD; Oegema TR; Brown DM
N Engl J Med; 1983 Oct; 309(17):1001-9. PubMed ID: 6225948
[TBL] [Abstract][Full Text] [Related]
6. The role of heparanase and the endothelial glycocalyx in the development of proteinuria.
Garsen M; Rops AL; Rabelink TJ; Berden JH; van der Vlag J
Nephrol Dial Transplant; 2014 Jan; 29(1):49-55. PubMed ID: 24166469
[TBL] [Abstract][Full Text] [Related]
7. Glomerular basement membrane heparan sulfate glycosaminoglycan in aminonucleoside of puromycin nephrosis.
Garin EH; Shirey AJ
Child Nephrol Urol; 1988-1989; 9(3):121-6. PubMed ID: 2978121
[TBL] [Abstract][Full Text] [Related]
8. Revisiting the glomerular charge barrier in the molecular era.
Harvey SJ; Miner JH
Curr Opin Nephrol Hypertens; 2008 Jul; 17(4):393-8. PubMed ID: 18660676
[TBL] [Abstract][Full Text] [Related]
9. The glomerular basement membrane as a model system to study the bioactivity of heparan sulfate glycosaminoglycans.
McCarthy KJ; Wassenhove-McCarthy DJ
Microsc Microanal; 2012 Feb; 18(1):3-21. PubMed ID: 22258721
[TBL] [Abstract][Full Text] [Related]
10. The role of heparan sulfate in the glomerular basement membrane.
Morita H; Yoshimura A; Kimata K
Kidney Int; 2008 Feb; 73(3):247-8. PubMed ID: 18195692
[TBL] [Abstract][Full Text] [Related]
11. Induction of glomerular heparanase expression in rats with adriamycin nephropathy is regulated by reactive oxygen species and the renin-angiotensin system.
Kramer A; van den Hoven M; Rops A; Wijnhoven T; van den Heuvel L; Lensen J; van Kuppevelt T; van Goor H; van der Vlag J; Navis G; Berden JH
J Am Soc Nephrol; 2006 Sep; 17(9):2513-20. PubMed ID: 16899518
[TBL] [Abstract][Full Text] [Related]
12. The role of heparanase in diseases of the glomeruli.
Szymczak M; Kuźniar J; Klinger M
Arch Immunol Ther Exp (Warsz); 2010 Feb; 58(1):45-56. PubMed ID: 20049646
[TBL] [Abstract][Full Text] [Related]
13. In vivo fragmentation of heparan sulfate by heparanase overexpression renders mice resistant to amyloid protein A amyloidosis.
Li JP; Galvis ML; Gong F; Zhang X; Zcharia E; Metzger S; Vlodavsky I; Kisilevsky R; Lindahl U
Proc Natl Acad Sci U S A; 2005 May; 102(18):6473-7. PubMed ID: 15843464
[TBL] [Abstract][Full Text] [Related]
14. Reduction of heparan sulphate-associated anionic sites in the glomerular basement membrane of rats with streptozotocin-induced diabetic nephropathy.
van den Born J; van Kraats AA; Bakker MA; Assmann KJ; Dijkman HB; van der Laak JA; Berden JH
Diabetologia; 1995 Oct; 38(10):1169-75. PubMed ID: 8690168
[TBL] [Abstract][Full Text] [Related]
15. In vivo degradation of heparan sulfates in the glomerular basement membrane does not result in proteinuria.
Wijnhoven TJ; Lensen JF; Wismans RG; Lamrani M; Monnens LA; Wevers RA; Rops AL; van der Vlag J; Berden JH; van den Heuvel LP; van Kuppevelt TH
J Am Soc Nephrol; 2007 Mar; 18(3):823-32. PubMed ID: 17251387
[TBL] [Abstract][Full Text] [Related]
16. Selective proteinuria in diabetic nephropathy in the rat is associated with a relative decrease in glomerular basement membrane heparan sulphate.
van den Born J; van Kraats AA; Bakker MA; Assmann KJ; van den Heuvel LP; Veerkamp JH; Berden JH
Diabetologia; 1995 Feb; 38(2):161-72. PubMed ID: 7713310
[TBL] [Abstract][Full Text] [Related]
17. Heparanase in Kidney Disease.
van der Vlag J; Buijsers B
Adv Exp Med Biol; 2020; 1221():647-667. PubMed ID: 32274730
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D attenuates proteinuria by inhibition of heparanase expression in the podocyte.
Garsen M; Sonneveld R; Rops AL; Huntink S; van Kuppevelt TH; Rabelink TJ; Hoenderop JG; Berden JH; Nijenhuis T; van der Vlag J
J Pathol; 2015 Dec; 237(4):472-81. PubMed ID: 26202309
[TBL] [Abstract][Full Text] [Related]
19. Glomerular permeability is not affected by heparan sulfate glycosaminoglycan deficiency in zebrafish embryos.
Khalil R; Lalai RA; Wiweger MI; Avramut CM; Koster AJ; Spaink HP; Bruijn JA; Hogendoorn PCW; Baelde HJ
Am J Physiol Renal Physiol; 2019 Nov; 317(5):F1211-F1216. PubMed ID: 31461353
[TBL] [Abstract][Full Text] [Related]
20. Hyperoside pre-treatment prevents glomerular basement membrane damage in diabetic nephropathy by inhibiting podocyte heparanase expression.
An X; Zhang L; Yuan Y; Wang B; Yao Q; Li L; Zhang J; He M; Zhang J
Sci Rep; 2017 Jul; 7(1):6413. PubMed ID: 28743882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]